Colorectal cancer— the cancer that begins in the colon or rectum, as the name suggests— is one of the most common types of ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...

Single-celled organisms called archaea aren't generally thought to cause human disease, but one species has been implicated in colorectal cancer ...

Anita Turk, MD, discusses abstracts from ASCO 2025 highlight the evolving role of ctDNA in the management of colorectal ...

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

A 2022 study claims to have found that a certain blood type is linked to a higher risk of colorectal cancer. Colorectal ...

The number of colorectal cancer cases in people under 50 is rising worldwide, especially in high-income countries. Possible ...

Fruzaqla was licensed by Takeda from China's Hutchmed for $400 million upfront in 2023 and has also been approved in the US ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

I want to know more about how exercising gives you a better chance of recovering from colon cancer. I've been trying to help ...

An otherwise active, healthy 39-year-old, Marisa Peters was a mother of three boys and still nursing her 16-month-old when she was initially diagnosed with Stage 3 rectal cancer.

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.